Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action

Suriyan Ponnusamy, Eric Lattmann, Pornthip Lattmann, Thirumagal Thiyagarajan, Balaram N. Padinjarethalakal, Ramesh Narayanan*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action'. Together they form a unique fingerprint.

Medicine & Life Sciences